TBA
GILD icon

Tower Bridge Advisors’s Gilead Sciences GILD Stock Holding History

Tower Bridge Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,405
Closed -$249K – 194
2024
Q1 		$249K Hold
3,405
– – 0.03% 185
2023
Q4 		$276K Hold
3,405
– – 0.02% 196
2023
Q3 		$255K Hold
3,405
– – 0.02% 202
2023
Q2 		$262K Hold
3,405
– – 0.02% 184
2023
Q1 		$282K Hold
3,405
– – 0.02% 207
2022
Q4 		$292K Hold
3,405
– – 0.02% 209
2022
Q3 		$210K Hold
3,405
– – 0.02% 221
2022
Q2 		$210K Hold
3,405
– – 0.02% 233
2022
Q1 		$202K Sell
3,405
-800
-19% -$51.1K 0.01% 247
2021
Q4 		$305K Sell
4,205
-842
-17% -$58K 0.02% 225
2021
Q3 		$353K Sell
5,047
-201
-4% -$14.1K 0.02% 211
2021
Q2 		$361K Sell
5,248
-200
-4% -$13.4K 0.02% 204
2021
Q1 		$352K Sell
5,448
-855
-14% -$55.1K 0.03% 196
2020
Q4 		$367K Buy
+6,303
New +$380K 0.03% 189
2018
Q1 		– Sell
-3,219
Closed -$231K – 204
2017
Q4 		$231K Sell
3,219
-60
-2% -$4.56K 0.02% 194
2017
Q3 		$266K Sell
3,279
-500
-13% -$38.2K 0.03% 175
2017
Q2 		$267K Buy
3,779
+3
+0.1% +$200 0.03% 177
2017
Q1 		$256K Buy
3,776
+500
+15% +$35.2K 0.03% 185
2016
Q4 		$235K Hold
3,276
– – 0.03% 190
2016
Q3 		$259K Hold
3,276
– – 0.03% 182
2016
Q2 		$273K Sell
3,276
-1,720
-34% -$153K 0.03% 179
2016
Q1 		$459K Buy
4,996
+2,400
+92% +$216K 0.06% 151
2015
Q4 		$263K Sell
2,596
-90
-3% -$9.37K 0.03% 174
2015
Q3 		$264K Hold
2,686
– – 0.04% 174
2015
Q2 		$314K Hold
2,686
– – 0.04% 168
2015
Q1 		$264K Hold
2,686
– – 0.03% 176
2014
Q4 		$253K Hold
2,686
– – 0.03% 181
2014
Q3 		$286K Sell
2,686
-490
-15% -$48K 0.04% 171
2014
Q2 		$263K Sell
3,176
-200
-6% -$15.6K 0.03% 175
2014
Q1 		$239K Buy
+3,376
New +$265K 0.03% 178

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tower Bridge Advisors's GILD Position: Q2 2024 in Review

Tower Bridge Advisors sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 3,405 shares — an estimated $249K sold.

Tower Bridge Advisors first reported a position in GILD in Q1 2014 and held it in 30 quarters. The position peaked at $459K in Q1 2016. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Tower Bridge Advisors reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • Tower Bridge Advisors sold 3,405 Gilead Sciences shares in Q2 2024, an estimated $249K.
  • Tower Bridge Advisors first reported a position in Gilead Sciences in Q1 2014 and held it in 30 quarters.
  • Tower Bridge Advisors's Gilead Sciences position peaked at $459K in Q1 2016.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Tower Bridge Advisors's 13F filing for Q2 2024, filed 24 Jul 2024.